162 related articles for article (PubMed ID: 9356496)
21. [The form of alpha-ketoglutarate dehydrogenase showing no cooperative properties during substrate binding].
Gomazkova VS; Bunik VI; Buneeva OA
Biokhimiia; 1987 Jul; 52(7):1144-9. PubMed ID: 3663751
[TBL] [Abstract][Full Text] [Related]
22. Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases.
Iannaccone M; Titta F; Serretiello E; Monfregola M; Gentile V
Recent Pat CNS Drug Discov; 2014; 9(2):76-84. PubMed ID: 25386917
[TBL] [Abstract][Full Text] [Related]
23. Transglutaminase as the agent of neurodegenerative diseases due to polyglutamine expansion.
Kahlem P; Green H; Djian P
Pathol Biol (Paris); 1998 Nov; 46(9):681-2. PubMed ID: 9885815
[No Abstract] [Full Text] [Related]
24. Interaction between glyceraldehyde-3-phosphate-dehydrogenase and lactate dehydrogenase.
Sukhodolets MV; Muronetz VI; Nagradova NK
Biochem Int; 1989 Aug; 19(2):379-84. PubMed ID: 2818602
[TBL] [Abstract][Full Text] [Related]
25. A novel D-glyceraldehyde-3-phosphate binding protein, a truncated albumin, with D-glyceraldehyde-3-phosphate dehydrogenase inhibitory property.
Roy A; Bera S; Patra S; Ray S; Ray M
IUBMB Life; 2009 Oct; 61(10):995-1000. PubMed ID: 19603513
[TBL] [Abstract][Full Text] [Related]
26. Evidence for the two phosphate binding sites of an analogue of the thioacyl intermediate for the Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase-catalyzed reaction, from its crystal structure.
Castilho MS; Pavão F; Oliva G; Ladame S; Willson M; Périé J
Biochemistry; 2003 Jun; 42(23):7143-51. PubMed ID: 12795610
[TBL] [Abstract][Full Text] [Related]
27. Glyceraldehyde-3-phosphate dehydrogenase inactivation by peroxynitrite.
Souza JM; Radi R
Arch Biochem Biophys; 1998 Dec; 360(2):187-94. PubMed ID: 9851830
[TBL] [Abstract][Full Text] [Related]
28. Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.
Iannaccone M; Serretiello E; De Vivo G; Martin A; Stefanile A; Titta F; Gentile V
Recent Pat CNS Drug Discov; 2013 Aug; 8(2):161-8. PubMed ID: 23688272
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a substrate assisted conformational transformation of glyceraldehyde 3-phosphate dehydrogenase.
Malhotra OP; Srinivasan ; Srivastava DK
Biochem Int; 1983 Sep; 7(3):379-86. PubMed ID: 6679347
[TBL] [Abstract][Full Text] [Related]
30. Insights into tyrosine phosphorylation control of protein-protein association from the NMR structure of a band 3 peptide inhibitor bound to glyceraldehyde-3-phosphate dehydrogenase.
Eisenmesser EZ; Post CB
Biochemistry; 1998 Jan; 37(3):867-77. PubMed ID: 9454576
[TBL] [Abstract][Full Text] [Related]
31. The cell adhesion molecule C-CAM is a substrate for tissue transglutaminase.
Hunter I; Sigmundsson K; Beauchemin N; Obrink B
FEBS Lett; 1998 Mar; 425(1):141-4. PubMed ID: 9541024
[TBL] [Abstract][Full Text] [Related]
32. The length of polyglutamine tract, its level of expression, the rate of degradation, and the transglutaminase activity influence the formation of intracellular aggregates.
de Cristofaro T; Affaitati A; Cariello L; Avvedimento EV; Varrone S
Biochem Biophys Res Commun; 1999 Jun; 260(1):150-8. PubMed ID: 10381359
[TBL] [Abstract][Full Text] [Related]
33. Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
Iannaccone M; Titta F; Serretiello E; De Vivo G; Martin A; Gentile V
Recent Pat CNS Drug Discov; 2013 Dec; 8(3):235-42. PubMed ID: 24286449
[TBL] [Abstract][Full Text] [Related]
34. GAPDH binders as potential drugs for the therapy of polyglutamine diseases: design of a new screening assay.
Lazarev VF; Benken KA; Semenyuk PI; Sarantseva SV; Bolshakova OI; Mikhaylova ER; Muronetz VI; Guzhova IV; Margulis BA
FEBS Lett; 2015 Feb; 589(5):581-7. PubMed ID: 25625921
[TBL] [Abstract][Full Text] [Related]
35. Molecular association of glucose-6-phosphate isomerase and pyruvate kinase M2 with glyceraldehyde-3-phosphate dehydrogenase in cancer cells.
Das MR; Bag AK; Saha S; Ghosh A; Dey SK; Das P; Mandal C; Ray S; Chakrabarti S; Ray M; Jana SS
BMC Cancer; 2016 Feb; 16():152. PubMed ID: 26911935
[TBL] [Abstract][Full Text] [Related]
36. Phosphonate analogues of alpha-ketoglutarate inhibit the activity of the alpha-ketoglutarate dehydrogenase complex isolated from brain and in cultured cells.
Bunik VI; Denton TT; Xu H; Thompson CM; Cooper AJ; Gibson GE
Biochemistry; 2005 Aug; 44(31):10552-61. PubMed ID: 16060664
[TBL] [Abstract][Full Text] [Related]
37. The effect of tyrosinase on glyceraldehyde-3-phosphate dehydrogenase and glycerophosphate dehydrogenase.
Solti M; Telegdi M
Acta Biochim Biophys Acad Sci Hung; 1972; 7(3):227-32. PubMed ID: 4369299
[No Abstract] [Full Text] [Related]
38. [Functional role of histidine residues of alpha-ketoglutarate dehydrogenase].
Bunik VI; Gomazkova VS
Biokhimiia; 1987 Aug; 52(8):1235-47. PubMed ID: 3663761
[TBL] [Abstract][Full Text] [Related]
39. [Non-equivalency of active centers of alpha-ketoglutarate dehydrogenase detected by modification of histidine residues].
Bunik VI; Gomazkova VS
Biokhimiia; 1985 Oct; 50(10):1668-75. PubMed ID: 4074777
[TBL] [Abstract][Full Text] [Related]
40. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase works as an arsenate reductase in human red blood cells and rat liver cytosol.
Gregus Z; Németi B
Toxicol Sci; 2005 Jun; 85(2):859-69. PubMed ID: 15788719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
